Titan Pharmaceuticals Schedules Conference Call to Review Fourth Quarter and Full Year 2011 Financial Results March 14, 2012
Titan Pharmaceuticals to Participate in RBC Capital Markets Global Healthcare Conference February 23, 2012
Titan Pharmaceuticals Announces Positive Results of Six-Month Open-Label Safety Retreatment Study of Probuphine February 9, 2012
Titan Pharmaceuticals Adopts Stockholder Rights Plan, Files Shelf Registration of Securities on Form S-3 December 21, 2011
Titan Pharmaceuticals Announces Probuphine Presentation at American Society of Addiction Medicine Conference October 20, 2011
Titan Pharmaceuticals Provides Additional Positive Results in Confirmatory Phase 3 Trial of Probuphine August 16, 2011
Titan Pharmaceuticals Schedules Conference Call to Review Second Quarter 2011 Financial Results and Probuphine Phase 3 Clinical Study Results August 9, 2011
